NICU Parent Education Program
- Conditions
- Neurodevelopmental OutcomesPremature InfantLanguage Development
- Registration Number
- NCT02528227
- Lead Sponsor
- Women and Infants Hospital of Rhode Island
- Brief Summary
The purpose of this study is to adminster one of two education programs to parents of preterm infants in the NICU to evaluate language and cognitive outcomes of their infants.
- Detailed Description
The long term goal of this research is to determine the language environment necessary in the NICU for very preterm infants to optimize their long-term language and cognitive development. This study will pilot an early language intervention with parents of preterm infants in the NICU the purpose of which is to provide a structured curriculum for the family to guide their language interactions with their infant. The aim is to increase the adult word counts and conversational turns in the NICU and to improve Bayley III language and cognitive scores at 12 months and 24 months corrected age.
The hypotheses is that increasing early language exposure in the NICU will result in improved lanugage and cognitive scores. The investigators plan on testing the hypothesis by the following specific aims.
1. Determine the effectiveness of a structured language curriculum with parents of preterm infants in the NICU on increasing the amount of early language exposure.
2. Test the the hypothesis that increased early language exposure will result in higher Bayley III language and cognitive scores.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 95
- Receiving care at Women & Infants' Hospital NICU,
- Providence RI gestational age 23 - 32 weeks,
- RI resident
- Unable to understand or speak English,
- congenital or chromosomal disorder likely to affect cognitive or speech development,
- parental loss of custody
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Bayley III Expressive Language Score 24 months Bayley III Expressive Language (mean 10, standard deviation 3)
Bayley III Receptive Language Score 24 months Bayley III Receptive Language (mean 10, standard deviation 3)
Bayley III cognitive composite score 24 months Bayley III cognitive score (mean 100, standard deviation 15)
Bayley III language composite score 24 months Bayley III Language score (mean 100, standard deviation 15)
Bayley III Motor Composite score 24 months Bayley III Motor composite score (mean 100, standard deviation 15)
- Secondary Outcome Measures
Name Time Method Bayley III motor composite score 12 month Bayley III motor score (mean 100, standard deviation 15)
Adult word count Count 32 weeks post menstrual age LENA recordings of adult word count (softward derived number of adult words spoken during a 16 hour period).
Bayley III receptive language score 12 month (mean 10, standard deviation 3) Bayley III receptive language score (mean 100, standard deviation 15)
Infant vocalizations Count 36 weeks post menstrual age LENA recordings of infant vocalizations (software derived recording of all speech related sounds recorded in a 16 hour time period).
Conversational turns Count 36 weeks post menstrual age LENA recordings of infant-parent conversational turns (softward derived recording of adult-child interactions that estimates the number of reciprocal vocalizations between infant and adult within 5 seconds, and recorded for a 16 hour time period).
Adult word count 36 weeks post menstrual age LENA recordings of adult word count (softward derived number of adult words spoken during a 16 hour period).
Bayley III cognitive composite score 12 month Bayley III cognitive score (mean 100, standard deviation 15)
Bayley III expressive language score 12 month (mean 10, standard deviation 3) Bayley III expressive language score (mean 100, standard deviation 15)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Women and Infants' Hospital
🇺🇸Providence, Rhode Island, United States
Women and Infants' Hospital🇺🇸Providence, Rhode Island, United States